SPDR S&P Biotech ETF
193 hedge funds and large institutions have $3.95B invested in SPDR S&P Biotech ETF in 2015 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 52 increasing their positions, 68 reducing their positions, and 20 closing their positions.
Holders
193
Holders Change
+13
Holders Change %
+7.22%
% of All Funds
5.2%
Holding in Top 10
11
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+10%
% of All Funds
0.3%
New
34
Increased
52
Reduced
68
Closed
20
Calls
$689M
Puts
$2.06B
Net Calls
-$1.38B
Net Calls Change
-$920M
Top Buyers
| 1 |
1
Goldman Sachs
New York
|
$1.1B |
| 2 |
2
BNP Paribas Financial Markets
Paris,
France
|
$316M |
| 3 |
3
Morgan Stanley
New York
|
$563M |
| 4 |
4
Citigroup
New York
|
$318M |
| 5 |
CS
5
Credit Suisse
Zurich,
Switzerland
|
$104M |
